title: Motesanib diphosphate (AMG 706), an oral angiogenesis inhibitor, demonstrates clinical efficacy in advanced thymoma.
authors.forename: Arun
authors.initials: A
authors.lastname: Azad
authors.forename: Rebecca A
authors.initials: RA
authors.lastname: Herbertson
authors.forename: David
authors.initials: D
authors.lastname: Pook
authors.forename: Shane
authors.initials: S
authors.lastname: White
authors.forename: Paul L R
authors.initials: PL
authors.lastname: Mitchell
authors.forename: Niall C
authors.initials: NC
authors.lastname: Tebbutt
mesh_terms: D000284:Administration, Oral; D000328:Adult; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D006801:Humans; D007211:Indoles / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D018365:Neoplasm, Residual / Q000188:drug therapy; D009536:Niacinamide / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D009841:Oligonucleotides; D010997:Pleural Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D018714:Radiotherapy, Adjuvant; D013945:Thymoma / Q000188:drug therapy* / Q000532:radiotherapy / Q000556:secondary* / Q000601:surgery; D013953:Thymus Neoplasms / Q000473:pathology* / Q000532:radiotherapy / Q000601:surgery; D016896:Treatment Outcome
chemical_list: D020533:Angiogenesis Inhibitors; D007211:Indoles; D009841:Oligonucleotides; D009536:Niacinamide; C519562:imetelstat